Jagdip S Powar, MD
Obstetrics/Gynecology · Palo Alto
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 10
- 2 carriers
- Office
- 1
Offices
1 location · Lpch Medical Group Div of Lucile · 332 clinicians in this group
Looking this up.
Hospitals listed: Stanford Health Care. That is not proof they admit you there this week.
Plans that list them
10 plans · 2 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Powar’s office at (650) 498-7200 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
10 of 10 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
California Medical Board record
Licence A35206 · Current
Licensed to practise in California · since 1980 · expires 2028-01-31 · University of Pune, Armed Forces Medical College.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for Stanford Health Care
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.31 (4.24 to 6.37) · 8,661 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.1 (12.7 to 15.7) · 2,191 cases | Worse | Jan 2024 – Dec 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.08 (1.95 to 6.21) · 5,296 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,348 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.45 to 1.67) · 5,374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.72 to 1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.09 (137.88 to 194.3) · 470 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.1 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.7 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.3 · 880 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 935 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 501 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.1 · 7,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.27) · 20,799 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.14 to 0.43) · 23,182 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.94 (0.2 to 1.68) · 5,694 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.54 to 3.19) · 7,846 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (3.76 to 6.64) · 5,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.38 (0.23 to 2.53) · 2,211 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0.21 to 0.83) · 19,915 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 416 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.869 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.857 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.368 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.2 · 247 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,021 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 47.8 · 258 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 990 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 976 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 959 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.4 to 6.2) · 2,191 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 425 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 183 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.4 to 15.4) · 4,578 cases | No different | Jan 2022 – Dec 2024 |
What patients said (6,810 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$8,066
Medicare paid this office $8,066 for 57 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Short return visit (20+ min) | 18 | $2,132 | $82 |
| Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | 34 | $1,949 | $57 |
| Cervical or vaginal cancer screening; pelvic and clinical breast examination | 34 | $1,626 | $48 |
Who their Medicare patients are
57 Original Medicare patients in 2024. Average age 75 · Women 100% · Health risk score 0.81. At or below the middle of the specialty; the typical obstetrics & gynecology clinician is at 0.88.
Conditions among them: High blood pressure 44% · Coronary heart disease 21%.
The office billed $29,320, Medicare allowed $9,611 and paid $8,066; for 115 services of 10 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 57 | 115 | 75 | 0.81 | $29,320 | $8,066 |
| 2023 | 48 | 100 | 74 | 0.66 | $26,858 | $7,478 |
| 2022 | 53 | 125 | 73 | 0.74 | $32,332 | $9,028 |
| 2021 | 49 | 112 | 74 | 0.66 | $37,756 | $9,708 |
| 2020 | 41 | 100 | 73 | 0.71 | $25,987 | $6,817 |
| 2019 | 44 | 99 | 74 | 0.61 | $27,100 | $6,814 |
| 2018 | 51 | 111 | 74 | 0.70 | $30,645 | $7,796 |
| 2017 | 79 | 163 | 74 | 0.71 | $41,684 | $10,665 |
| 2016 | 78 | 128 | 73 | 0.75 | $49,229 | $13,280 |
| 2015 | 93 | 148 | 72 | 0.60 | $48,028 | $13,097 |
| 2014 | 107 | 163 | 73 | 0.63 | $51,111 | $15,563 |
| 2013 | 122 | 196 | 73 | 0.72 | $81,003 | $17,721 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 3 services
| Short return visit (20+ min) | 12 | $1,652 | $87 |
| Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | 29 | $1,621 | $56 |
| Cervical or vaginal cancer screening; pelvic and clinical breast examination | 28 | $1,338 | $48 |
2022: 3 services
| Short return visit (20+ min) | 13 | $2,575 | $83 |
| Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | 31 | $1,706 | $55 |
| Cervical or vaginal cancer screening; pelvic and clinical breast examination | 31 | $1,480 | $48 |
2021: 2 services
| Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | 30 | $1,673 | $56 |
| Cervical or vaginal cancer screening; pelvic and clinical breast examination | 31 | $1,503 | $48 |
2020: 3 services
| Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | 31 | $1,693 | $55 |
| Cervical or vaginal cancer screening; pelvic and clinical breast examination | 32 | $1,540 | $48 |
| Short return visit (20+ min) | 16 | $1,239 | $62 |
2019: 3 services
| Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | 27 | $1,456 | $54 |
| Cervical or vaginal cancer screening; pelvic and clinical breast examination | 28 | $1,305 | $47 |
| Short return visit (20+ min) | 14 | $847 | $56 |
2018: 2 services
| Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | 34 | $1,753 | $52 |
| Cervical or vaginal cancer screening; pelvic and clinical breast examination | 33 | $1,403 | $43 |
2017: 4 services
| Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | 41 | $2,079 | $51 |
| Cervical or vaginal cancer screening; pelvic and clinical breast examination | 45 | $1,886 | $42 |
| Return visit (30+ min) | 22 | $1,335 | $53 |
| Short return visit (20+ min) | 14 | $1,326 | $58 |
2016: 4 services
| Return visit (30+ min) | 50 | $4,315 | $83 |
| New patient visit (45+ min) | 12 | $1,717 | $143 |
| Short return visit (20+ min) | 16 | $1,553 | $58 |
| Ultrasound scan of uterus, ovaries, tubes, cervix and pelvic area through vagina | 11 | $1,223 | $111 |
2015: 3 services
| Return visit (30+ min) | 73 | $6,621 | $80 |
| Short return visit (20+ min) | 20 | $1,709 | $63 |
| Ultrasound scan of uterus, ovaries, tubes, cervix and pelvic area through vagina | 14 | $1,630 | $116 |
2014: 3 services
| Return visit (30+ min) | 94 | $9,861 | $87 |
| Ultrasound scan of uterus, ovaries, tubes, cervix and pelvic area through vagina | 16 | $2,327 | $122 |
| New patient visit (45+ min) | 11 | $1,554 | $141 |
2013: 4 services
| Return visit (30+ min) | 94 | $8,864 | $85 |
| Short return visit (20+ min) | 25 | $2,142 | $55 |
| New patient visit (45+ min) | 12 | $1,649 | $137 |
| Ultrasound scan of uterus, ovaries, tubes, cervix and pelvic area through vagina | 21 | $1,550 | $67 |
Drugs they prescribed that Part D paid
$26,592
Pharmacies billed $26,592 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 216) in 2024. At or below the middle of the specialty; the typical obstetrics & gynecology clinician is at 0%.
146 generic and 70 brand-name prescriptions · $26,592 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Estradiol | 62 | $4,645 | $75 |
| Prempro | 14 | $4,245 | $303 |
| Minivelle | 11 | $2,918 | $265 |
| Progesterone | 21 | $551 | $26 |
Year by year
| 2024 | 216 | 55 | 0% (0) | 32% | $26,592 |
| 2023 | 157 | 41 | 0% (0) | 32% | $23,268 |
| 2022 | 143 | 29 | 0% (0) | 43% | $26,998 |
| 2021 | 132 | 25 | None | 29% | $23,875 |
| 2020 | 118 | 29 | 0% (0) | 37% | $22,793 |
| 2019 | 113 | 28 | 0% (0) | 50% | $21,915 |
| 2018 | 175 | 37 | 0% (0) | 46% | $38,809 |
| 2017 | 213 | 48 | 0% (0) | 47% | $36,891 |
| 2016 | 193 | 45 | None | 49% | $31,431 |
| 2015 | 181 | 49 | None | 65% | $34,651 |
| 2014 | 171 | 46 | 0% (0) | 74% | $25,928 |
| 2013 | 229 | 50 | None | 67% | $25,811 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 3 drugs
| Premarin | 14 | $3,679 | $263 |
| Estradiol | 34 | $3,111 | $91 |
| Progesterone | 16 | $1,267 | $79 |
2022: 2 drugs
| Premarin | 25 | $6,858 | $274 |
| Estradiol | 30 | $3,464 | $115 |
2021: 3 drugs
| Premarin | 15 | $5,426 | $362 |
| Prempro | 15 | $5,113 | $341 |
| Estradiol | 27 | $3,477 | $129 |
2020: 3 drugs
| Premarin | 13 | $5,543 | $426 |
| Prempro | 15 | $4,349 | $290 |
| Estradiol | 19 | $3,693 | $194 |
2019: 3 drugs
| Premarin | 24 | $6,724 | $280 |
| Estradiol | 15 | $4,128 | $275 |
| Prempro | 16 | $3,397 | $212 |
2018: 6 drugs
| Premarin | 24 | $10,094 | $421 |
| Estring | 15 | $6,228 | $415 |
| Yuvafem | 18 | $4,534 | $252 |
| Estradiol | 29 | $4,313 | $149 |
| Prempro | 16 | $3,960 | $247 |
| Oxazepam | 13 | $395 | $30 |
2017: 5 drugs
| Premarin | 36 | $10,552 | $293 |
| Prempro | 18 | $4,441 | $247 |
| Estradiol | 22 | $3,636 | $165 |
| Oxazepam | 12 | $247 | $21 |
| Sulfamethoxazole-Trimethoprim | 11 | $33 | $3 |
2016: 4 drugs
| Premarin | 30 | $9,378 | $313 |
| Prempro | 21 | $6,098 | $290 |
| Vagifem | 11 | $3,040 | $276 |
| Oxazepam | 13 | $271 | $21 |
2015: 5 drugs
| Premarin | 44 | $12,224 | $278 |
| Vagifem | 24 | $6,274 | $261 |
| Prempro | 18 | $4,714 | $262 |
| Estring | 13 | $3,385 | $260 |
| Oxazepam | 11 | $156 | $14 |
2014: 4 drugs
| Premarin | 39 | $8,034 | $206 |
| Vagifem | 24 | $4,960 | $207 |
| Estring | 13 | $2,997 | $231 |
| Synthroid | 13 | $352 | $27 |
2013: 4 drugs
| Premarin | 73 | $11,578 | $159 |
| Vagifem | 17 | $2,794 | $164 |
| Levothyroxine | 12 | $108 | $9 |
| Ciprofloxacin | 12 | $59 | $5 |
Money from drug and device companies
$38 in 2020
A payment is not proof that care is biased.
| Aspira Women's Health | Ova1 | $38 | 1 payment
|
See the published payment
| Aspira Women's Health | Meals · 2020-01-22 | Ova1 | $38 |
Professional record
- NPI
- 1972527802
- Licence
- CA A35206California A35206: Current · expires 2028-01-31
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207V00000X (207V00000X)
- Mailing address
- 211 Quarry Rd, Suite 107, Mail Code 5997, Palo Alto, CA, 94304
- NPI first listed
- 2006-07-26
- NPI last updated
- 2013-01-04
This is when the NPI record was last certified, not a medical board exam.